Literature DB >> 29259857

Differences of basic and induced autophagic activity between K562 and K562/ADM cells.

Feifei Wang1,2,3,4, Jing Chen5, Zhewen Zhang5, Juan Yi5, Minmin Yuan1,2,3,4, Mingyan Wang1,2,3,4, Na Zhang1,2,3,4, Xuemin Qiu1,2,3,4, Hulai Wei5, Ling Wang1,2,3,4.   

Abstract

Patients with acute myeloid leukemia (AML) often have a poor prognosis due to drug resistance, which is regarded as a tough problem during the period of clinical therapeutics. It has been reported that autophagy, an important event in various cellular processes, plays a crucial role in mediating drug-resistance to cancer cells. Our study attempts to comparatively investigate the differences of basic and induced autophagic activity between drug-sensitive and multidrug-resistant AML cells. The level of basic autophagy in K562/ADM cells was higher than that in K562 cells, which could be characterized by more cytosolic contents-packaged autophagic vacuoles in K562/ADM cells when compared to that in K562 cells. The observation of MDC staining showed that the fluorescent intensity of autophagosomes in K562/ADM cells was stronger than that in K562 cells. The expression of Beclin1 and the ratio of LC3-II to LC3-I were distinctly higher in K562/ADM cells, however, P62 protein was relatively lower in K562/ADM cells. Furthermore, we found that nutrient depletion could induce autophagic activity of both cell lines. However, autophagic activity of K562/ADM cells was always maintained at a higher level in contrast with K562 cells. ADM (Adriamycin) was also capable of inducing autophagic activity of K562 and K562/ADM cells, but the autophagic alteration in K562 cells appeared earlier. Taken together, our findings suggest that autophagy exerts an important effect on formation and maintenance of drug-resistance in AML cells.

Entities:  

Keywords:  Autophagic activity; acute myeloid leukemia; drug-resistance

Year:  2017        PMID: 29259857      PMCID: PMC5735282          DOI: 10.5582/irdr.2017.01069

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  44 in total

Review 1.  Moving toward targeted therapies in acute myeloid leukemia.

Authors:  Weiqiang Gao; Elihu Estey
Journal:  Clin Adv Hematol Oncol       Date:  2015-11

Review 2.  Anatomy of autophagy: from the beginning to the end.

Authors:  Xiaoyong Zhi; Wenzhi Feng; Yueguang Rong; Rong Liu
Journal:  Cell Mol Life Sci       Date:  2017-09-22       Impact factor: 9.261

3.  EBV Infection Empowers Human B Cells for Autoimmunity: Role of Autophagy and Relevance to Multiple Sclerosis.

Authors:  Elena Morandi; S Anwar Jagessar; Bert A 't Hart; Bruno Gran
Journal:  J Immunol       Date:  2017-06-07       Impact factor: 5.422

4.  Autophagy in drug resistance of the multiple myeloma cell line RPMI8226 to doxorubicin.

Authors:  Y-Z Pan; X Wang; H Bai; C-B Wang; Q Zhang; R Xi
Journal:  Genet Mol Res       Date:  2015-05-25

5.  Knockdown of WAVE1 enhances apoptosis of leukemia cells by downregulating autophagy.

Authors:  Zhaoxia Zhang; Benqing Wu; Wenwen Chai; Lizhi Cao; Yangping Wang; Yan Yu; Liangchun Yang
Journal:  Int J Oncol       Date:  2016-03-18       Impact factor: 5.650

6.  Doxycycline synergizes with doxorubicin to inhibit the proliferation of castration-resistant prostate cancer cells.

Authors:  Chao Zhu; Xueting Yan; Ao Yu; Yongjian Wang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2017-11-01       Impact factor: 3.848

7.  Suppression of p53 potentiates chemosensitivity in nutrient-deprived cholangiocarcinoma cells via inhibition of autophagy.

Authors:  Fei Hu; Xian-Ling Guo; Shan-Shan Zhang; Qiu-Dong Zhao; Rong Li; Qing Xu; Li-Xin Wei
Journal:  Oncol Lett       Date:  2017-06-21       Impact factor: 2.967

8.  TRPC5-induced autophagy promotes drug resistance in breast carcinoma via CaMKKβ/AMPKα/mTOR pathway.

Authors:  Peng Zhang; Xiaoyu Liu; Hongjuan Li; Zhen Chen; Xiaoqiang Yao; Jian Jin; Xin Ma
Journal:  Sci Rep       Date:  2017-06-09       Impact factor: 4.379

9.  Distinct Dasatinib-Induced Mechanisms of Apoptotic Response and Exosome Release in Imatinib-Resistant Human Chronic Myeloid Leukemia Cells.

Authors:  Juan Liu; Yujing Zhang; Aichun Liu; Jinghua Wang; Lianqiao Li; Xi Chen; Xinyu Gao; Yanming Xue; Xiaomin Zhang; Yao Liu
Journal:  Int J Mol Sci       Date:  2016-04-08       Impact factor: 5.923

Review 10.  Autophagy in Cancer Therapy.

Authors:  Simone Fulda
Journal:  Front Oncol       Date:  2017-06-15       Impact factor: 6.244

View more
  3 in total

1.  miR-199a-5p Represses Protective Autophagy and Overcomes Chemoresistance by Directly Targeting DRAM1 in Acute Myeloid Leukemia.

Authors:  Yang Li; Guojun Zhang; Bin Wu; Wei Yang; Zhuogang Liu
Journal:  J Oncol       Date:  2019-09-15       Impact factor: 4.375

2.  MicroRNA‑145 promotes the apoptosis of leukemic stem cells and enhances drug‑resistant K562/ADM cell sensitivity to adriamycin via the regulation of ABCE1.

Authors:  Zhijun Wuxiao; Hua Wang; Qunhao Su; Haiyan Zhou; Min Hu; Shi Tao; Lu Xu; Yu Chen; Xinbao Hao
Journal:  Int J Mol Med       Date:  2020-07-15       Impact factor: 4.101

3.  Overcoming Basal Autophagy, Kangai Injection Enhances Cisplatin Cytotoxicity by Regulating FOXO3a-Dependent Autophagic Cell Death and Apoptosis in Human Lung Adenocarcinoma A549/DDP Cells.

Authors:  Huan Zhou; Pengyu Pan; Qiuyu Zhao; Wenjun Liu; Ye Sun; Jianbo Wang; Chunying Liu; Chun Wang
Journal:  Biomed Res Int       Date:  2022-09-01       Impact factor: 3.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.